作者
Peiyi Wang,Junliang Liu,Mattia Santoni,Gianfranco Picone,Zijian Cai,L. Laghi,Chenglin Zhu
摘要
According to the World Obesity Atlas 2025, the number of individuals with overweight or obesity in China is projected to exceed 515 million by 2030. Compared with conventional pharmacological therapies, probiotic dietary interventions have attracted increasing interest for obesity management because of their favorable safety profiles and health-promoting potential. In this study, fifteen Lactiplantibacillus plantarum strains were isolated from traditional fermented paocai. Probiotic-related properties were evaluated, and three promising strains (WJ-2, FY-2, and DJ3-2) were selected. These strains were subsequently assessed for lipid-modulating properties, antioxidant activity, and phenotypic safety. Based on its overall performance, L. plantarum WJ-2 was selected for whole-genome sequencing and in vivo validation in mice. The chromosome was 3,243,044 bp long and had a GC content of 44.51%. Genes associated with oxidative-stress responses ( katE, ndh, npr, trxA, trxB, tpx, and gor ), antimicrobial-resistance-related functions ( tetM, tetB, and blt ), and lipid-related functions ( bsh/cbh, yxeI, fabG, fabH, and fabF ) were annotated. In silico screening did not identify virulence genes or biogenic-amine synthesis genes, and ResFinder did not identify known transferable resistance determinants. Under the tested conditions, WJ-2 produced no apparent adverse effects on food intake, body-weight gain, or organ indices and selectively altered gut microbial composition. Overall, L. plantarum WJ-2 demonstrated favorable probiotic-related properties and warrants further evaluation as a candidate strain for probiotic formulations targeting obesity-related metabolic disturbances.